A carregar...

In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis.

CGI 17341 (2-ethyl-5-nitro-2,3-dihydro[2-1b]imidazo-oxazole) is a novel orally active representative of the 5-nitroimidazole series of antimicrobial agents. At concentrations ranging from 0.1 to 0.3 micrograms/ml, CGI 17341 inhibited the drug-susceptible and multi-drug-resistant strains of Mycobacte...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ashtekar, D R, Costa-Perira, R, Nagrajan, K, Vishvanathan, N, Bhatt, A D, Rittel, W
Formato: Artigo
Idioma:Inglês
Publicado em: 1993
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC187635/
https://ncbi.nlm.nih.gov/pubmed/8452346
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!